References
- 1. van den Berg K, van Hasselt J, Bloch E, Crookes R, Kelley J, Berger J, et al. A review of the use of blood and blood products in HIV-infected patients. South Afr J HIV Med. 2012;13(2):87-104.10.4102/sajhivmed.v13i2.146
- 2. Tracy RP. Inflammation markers and coronary heart disease. Curr Opin Lipidol. 1999 Oct;10(5):435-41.10.1097/00041433-199910000-00008
- 3. Fibrinogen Studies C, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005 Oct 12;294(14):1799-809.10.1001/jama.294.14.1799
- 4. Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, et al. C-Reactive Protein Is a Marker for Human Immunodeficiency Virus Disease Progression. Archives of Internal Medicine. 2006;166(1):64-70.10.1001/archinte.166.1.64
- 5. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008 Oct 21;5(10):e203.10.1371/journal.pmed.0050203